FDA Clearance Tracker · K232741
SmartAdjust(TM) technology
Last checked: Nov 19, 2026Latest source record: May 29, 2024 (this decision)Source: openFDAMethods & limitations
Decided
May 29, 2024
Substantially Equivalent
Time to decision
265 days
Received Sep 7, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K232741
- Device name
- SmartAdjust(TM) technology
- Applicant
- Insulet Corporation
- Applicant location
- Acton, MA
- Received
- Sep 7, 2023
- Decided
- May 29, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 862.1356
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QJI. The earliest in FDA's data is DEN190034, decided Dec 13, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232741
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Insulet Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Omnipod 6 algorithm510(k)
K261461 · Decided Jun 29, 2026 · 56 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- Omnipod 5 algorithm510(k)
K251779 · Decided Dec 3, 2025 · 176 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
- SmartAdjust Technology510(k)
K241777 · Decided Aug 26, 2024 · 67 days after receipt
Device type: Interoperable Automated Glycemic Controller (QJI) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.